Alamar Biosciences
Experience pTau and beyond with Alamar’s NULISAseq™ CNS Disease Panel 120, delivering biologically informed analysis with unmatched sensitivity and dynamic range. Now featuring brain-derived and peripheral pTau detection, the panel profiles 120+ proteins to power biomarker discovery and validation from blood, including key proteins such as GFAP, TDP-43, NfL, and alpha-synuclein. Paired with Alamar’s ARGO™ HT System, leverage a fully automated workflow requiring less than 30 minutes of total hands-on time from sample to data.
